D L Morton Selected Research

D L Morton Research Topics

Disease

28	Melanoma (Melanoma, Malignant) 08/2009 - 01/2000
24	Neoplasms (Cancer) 08/2009 - 01/2000
5	Neoplasm Micrometastasis 10/2001 - 03/2000
5	Neoplasm Metastasis (Metastasis) 08/2001 - 04/2000
2	Hypersensitivity (Allergy) 01/2004 - 06/2001
2	Carcinoma (Carcinomatosis) 05/2002 - 09/2000
2	Colonic Neoplasms (Colon Cancer) 06/2001 - 06/2000
1	Disease Progression 01/2004
1	Polyps 07/2001
1	Paralysis (Palsy) 06/2001
1	Colorectal Neoplasms (Colorectal Cancer) 03/2001
1	Breast Neoplasms (Breast Cancer) 02/2001
1	Lymphatic Metastasis 07/2000
1	Thrombocytopenia (Thrombopenia) 06/2000
1	Liver Neoplasms (Liver Cancer) 06/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2000
1	Adenocarcinoma 04/2000
1	Necrosis 04/2000
1	Lung Neoplasms (Lung Cancer) 01/2000
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2000

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 01/2004 - 04/2000
6	VaccinesIBA 01/2004 - 04/2000
6	Coloring Agents (Dyes)IBA 05/2002 - 08/2000
4	polyvalent melanoma cell vaccineIBA 01/2004 - 04/2001
4	Immunoglobulin M (IgM)IBA 01/2004 - 04/2000
3	Keratins (Keratin)IBA 07/2001 - 11/2000
2	Glycoproteins (Glycoprotein)IBA 01/2004 - 04/2001
2	AntibodiesIBA 01/2004 - 04/2000
2	CarbonIBA 08/2001 - 07/2001
2	Cell-Free Nucleic AcidsIBA 08/2001 - 04/2000
2	Genetic Markers (Genetic Marker)IBA 08/2001 - 04/2001
2	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 07/2001 - 08/2000
2	Immunoglobulins (Immunoglobulin)IBA 06/2001 - 04/2000
2	Biomarkers (Surrogate Marker)IBA 04/2001 - 04/2000
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2001 - 02/2001
2	ImmunosorbentsIBA 02/2001 - 04/2000
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2001 - 04/2000
2	EnzymesIBA 02/2001 - 04/2000
2	Carcinoembryonic AntigenIBA 09/2000 - 06/2000
2	GangliosidesIBA 04/2000 - 04/2000
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 08/2009
1	Immunoglobulin G (IgG)IBA 01/2004
1	CanvaxinIBA 01/2004
1	Cancer VaccinesIBA 01/2004
1	Oxidoreductases (Dehydrogenase)IBA 08/2001
1	chinese inkIBA 07/2001
1	Proteins (Proteins, Gene)FDA Link 06/2001
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2001
1	Melanoma-Specific AntigensIBA 06/2001
1	Tuberculin (PPD)IBA 06/2001
1	CytokinesIBA 06/2001
1	ParaffinIBA 04/2001
1	DNA (Deoxyribonucleic Acid)IBA 04/2001
1	TA90 immune complexIBA 02/2001
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 02/2001
1	Proto-Oncogene Proteins c-metIBA 02/2001
1	RNA (Ribonucleic Acid)IBA 02/2001
1	Tumor Biomarkers (Tumor Markers)IBA 01/2001
1	Monoclonal AntibodiesIBA 09/2000
1	CarbohydratesIBA 09/2000
1	SuspensionsIBA 04/2000
1	Dihydrotachysterol (AT 10)IBA 03/2000
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2000
1	Interleukin Receptor Common gamma SubunitIBA 01/2000
1	Interleukin-4 (Interleukin 4)IBA 01/2000
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2000
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2000
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2000
1	RadiopharmaceuticalsIBA 01/2000

Therapy/Procedure

13	Lymph Node Excision (Lymph Node Dissection) 08/2004 - 01/2000
12	Therapeutics 01/2004 - 01/2000
4	Immunotherapy 10/2001 - 04/2000
2	Cytoreduction Surgical Procedures 01/2004 - 07/2001
2	Aftercare (After-Treatment) 04/2001 - 01/2000
2	Adjuvant Chemotherapy 03/2001 - 02/2001
1	Colonoscopes 07/2001
1	Colectomy 07/2001
1	Lasers (Laser) 04/2001
1	Radiotherapy 09/2000
1	Adjuvant Radiotherapy 09/2000
1	Length of Stay 06/2000
1	Radiofrequency Ablation 06/2000